Maternal asthma medication use during pregnancy and risk of congenital heart defects

ConclusionWe did not observe statistically significant associations between the reported use of asthma medications during pregnancy and most specific types of CHDs. Despite limitations in our inability to evaluate asthma status and severity, our study suggests that maternal asthma medication use does not substantially, if at all, increase the risk of CHDs. Birth Defects Research (Part A), 2015. © 2015 Wiley Periodicals, Inc.

Source: Birth Defects Research Part A: Clinical and Molecular Teratology - September 1, 2015 Category: Perinatology & Neonatology Authors: Alissa R. Van Zutphen, Erin M. Bell, Marilyn L. Browne, Shao Lin, Angela E. Lin, Charlotte M. Druschel, Tags: Original Research Article Source Type: research